| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 56 | 2023 |
| Mammographic screening in routine practice: multisite study of digital breast tomosynthesis and digital mammography screenings EF Conant, MM Talley, CR Parghi, BC Sheh, SY Liang, S Pohlman, ... Radiology 307 (3), e221571, 2023 | 26 | 2023 |
| Comparative value of cholinesterase inhibitors and memantine in persons with moderate-to-severe Alzheimer’s disease in the United States: a cost-effectiveness analysis I Yunusa, S Alsahali, A Rane, T Eguale Journal of Alzheimer's Disease Reports 5 (1), 705-713, 2021 | 15 | 2021 |
| Cost-Effectiveness of Dapagliflozin vs Empagliflozin for Treating Heart Failure With Reduced Ejection Fraction in the United States RN Nechi, A Rane, RM Karaye, C Ndikumukiza, S Alsahali, AI Jatau, ... Clinical Therapeutics 45 (7), 627-632, 2023 | 2 | 2023 |
| PCN56 Contrast enhanced mammography (CEM) vs contrast enhanced breast MRI as a preoperative staging exam in women with newly diagnosed breast cancer: a budget impact analysis A Rane, S Pohlman Value in Health 24, S29, 2021 | 2 | 2021 |
| Comparative Efficacy and Safety of Pharmacological Interventions in Patients with Dementia-Related Agitation or Aggression: A Network Meta-Analysis A Rane, K Prabhune, C Okeke, N Chen, I Yunusa The American Journal of Geriatric Psychiatry 32 (4), S95-S96, 2024 | 1 | 2024 |
| Comparative value of dapagliflozin vs empagliflozin in patients with heart failure and preserved ejection fraction: A cost-effectiveness analysis A Rane, RN Nechi, M Imam, CR Zoni, C Ndikumukiza, IM Karaye, ... Journal of Managed Care & Specialty Pharmacy 29 (9), 1045-1053, 2023 | 1 | 2023 |
| P1‐568: THE INFLUENCE OF FDA‐APPROVED MEDICATIONS FOR ALZHEIMER'S DISEASE ON ITS CLINICAL PROGRESSION IN A LONGITUDINAL COHORT (2005‐2015) I Yunusa, A Rane, S Ihtisham, F Ida, A Garba, T Eguale Alzheimer's & Dementia 15, P492-P493, 2019 | 1 | 2019 |
| PDB43 SYSTEMATIC REVIEW OF THE COST EFFECTIVENESS ANALYSIS OF LIFESTYLE INTERVENTION VERSUS STANDARD CARE FOR PREVENTION OF TYPE 2 DIABETES P Gebrehiwet, A Rane Value in Health 22, S147, 2019 | 1 | 2019 |
| Association of Hemoglobin Levels with Healthcare Resource Utilization and Costs in Non-Transfusion-Dependent α-and β-Thalassemia: A Retrospective Observational Study Using Real … AL Langer, A Rane, L Lombard, KS Gilroy, J Li, J Zhao, CR Lew, ... Blood 142, 5244, 2023 | | 2023 |
| P1463: HEALTHCARE RESOURCE USE, ECONOMIC BURDEN AND IN-PATIENT MORTALITY IN PATIENTS WITH ALPHA-AND BETA-THALASSEMIA COMPARED TO MATCHED CONTROLS IN THE REAL-WORLD SETTING AL Langer, L Lombard, A Rane, K Gilroy, LI Junlong, J Zhao, C Lew, ... HemaSphere 7 (S3), e333151f, 2023 | | 2023 |
| RWD116 Hospitalizations Among Patients with Both Colorectal Cancer and Type II Diabetes Mellitus Treated with Metformin Vs. Sulfonylureas: A Seer-Medicare Analysis A Rane, S Reddy, S Kaliki, N Kaler, RK Dungrani, N Patel, IB Murimi Value in Health 26 (6), S383, 2023 | | 2023 |
| EE342 Evaluation of the Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin for Treating Heart Failure with Reduced Ejection Fraction in the United States R Nechi, A Rane, R Karaye, C Ndikumukiza, S Alsahali, A Jatau, CR Zoni, ... Value in Health 26 (6), S122, 2023 | | 2023 |
| EE219 Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction A Rane, RN Nechi, M Imam, CR Zoni, C Ndikumukiza, I Karaye, I Yunusa, ... Value in Health 26 (6), S99, 2023 | | 2023 |
| CO19 Relative Efficacy of Pharmacological Treatments of Agitation and Aggression in Patients with Dementia: A Systematic Review and Network Meta-Analysis A Rane, K Prabhune, N Chen, S Kaliki, I Yunusa Value in Health 26 (6), S17, 2023 | | 2023 |
| Healthcare Cost and Utilization of Uterus-Sparing Interventions in Women with Uterine Fibroids: A Retrospective Claims Analysis SL Lim, CJ Sobolewski, S Pohlman, A Rane, S Currigan Journal of Minimally Invasive Gynecology 29 (11), S1-S2, 2022 | | 2022 |
| PMD2 Laparoscopic Radiofrequency Ablation VS Laparoscopic Myomectomy in the Treatment of Symptomatic Uterine Leiomyomas: A Meta-Analysis of Randomized Controlled Trials A Rane, S Pohlman Value in Health 24, S123, 2021 | | 2021 |
| Cost and Diagnosis Patterns for Women with Postmenopausal Bleeding OV Tran, S Pohlman, A Rane, M Louie Journal of Minimally Invasive Gynecology 27 (7), S51, 2020 | | 2020 |
| PND47 COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATMENTS OF MODERATE-TO-SEVERE ALZHEIMER'S DISEASE I Yunusa, A Rane, I Sultan, T Eguale Value in Health 23, S267, 2020 | | 2020 |
| PSU11 SAFETY AND EFFICACY ANALYSIS OF ENOXAPARIN VERSUS RIVAROXABAN AFTER TOTAL HIP OR KNEE ARTHROPLASTY: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS P Gebrehiwet, A Rane, A Pande, J Doucette, T Eguale Value in Health 23, S366-S367, 2020 | | 2020 |
